Journal
IMMUNITY
Volume 26, Issue 2, Pages 241-255Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2007.01.011
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI63515] Funding Source: Medline
- NIAMS NIH HHS [AR53239] Funding Source: Medline
- Telethon [GJT04008] Funding Source: Medline
Ask authors/readers for more resources
We report here that leptin can act as a negative signal for the proliferation of human naturally occurring Foxp3(+)CD4(+)CD25(+) regulatory T (T-reg) cells. Freshly isolated Treg cells produced leptin and expressed high amounts of leptin receptor (ObR). In vitro neutralization with leptin monoclonal antibody (mAb), during anti-CD3 and anti-CD28 stimulation, resulted in T-reg cell proliferation, which was interleukin-2 (IL-2) dependent. Treg cells that proliferated in the presence of leptin mAb had increased expression of Foxp3 and remained suppressive. The phenomena appeared secondary to leptin signaling via ObR and, importantly, leptin neutralization reversed the anergic state of the Treg cells, as indicated by downmodulation of the cyclin-dependent kinase inhibitor p27 (p27(kip1)) and the phosphorylation of the extracellular-related kinases 1 (ERK1) and ERK2. Together with the finding of enhanced proliferation of T-reg cells observed in leptin- and ObR-deficient mice, these results suggest a potential for therapeutic interventions in immune and autoimmune diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available